Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FTC Asks FDA To Clarify "Orange Book" Listing Criteria In Citizen Petition

Related Content

GSK Paxil, AstraZeneca Prilosec Have New "Product By Process" Patents

Mar 26 2001

Bristol BuSpar Metabolite Data Requested By FDA Before Final Patent Listing

Dec 04 2000

Mylan Buspirone Launch Awaits Bristol Appeal Of BuSpar Patent Order

Mar 19 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window